Skip to main content
SpringerLink
Log in

Implementing pharmacy practice research programs for the management of heart failure

  • Conference Commentary
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

It stands to reason that pharmacists would have a benefic role in the treatment of patients with chronic illnesses wherein complicated pharmacotherapies are required to reduce the risk of acute exacerbation. For chronic heart failure, recent evidence bears this out. When pharmacists take time to provide self-care instructions for patients with heart failure or take part in collaborative healthcare teams, the need for costly urgent healthcare decreases with corresponding decreases in healthcare costs. Further research is needed to address the key supportive roles of pharmacists in the treatment of patients with heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HGM. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study. J. Cardiac Failure. 2003;9(5):404–11.

    Article  Google Scholar 

  2. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714–25.

    PubMed  Google Scholar 

  3. Tsuyuki RT, Fradette M, Johnson JA, et al. A multicenter disease management program for hospitalized patients with heart failure. J. Cardiac Failure. 2004;10(6):473–80.

    Article  Google Scholar 

  4. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: Long-term implications on readmission and survival. Circulation. 2002;105:2861–6.

    Article  PubMed  Google Scholar 

  5. Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med. 2005;165(11):1311; author reply 1311-1312.

    Google Scholar 

  6. Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacist’s role. Pharmacotherapy. 2007;27(4 Pt 2):18S–28S.

    Article  PubMed  Google Scholar 

  7. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757–63.

    Article  PubMed  Google Scholar 

  8. Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 2003;89(6):605–9.

    Article  CAS  PubMed  Google Scholar 

  9. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158(10):1108–12.

    Article  CAS  PubMed  Google Scholar 

  10. Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther. 2009;85(6):651–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Purdue University College of Pharmacy, West Lafayette, IN, 47907, USA

    Michael D. Murray

  2. Regenstrief Institute, Indianapolis, IN, 46202-3012, USA

    Michael D. Murray

Authors
  1. Michael D. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael D. Murray.

Additional information

This paper describes a lecture to be given at the 39th European Symposium of Clinical Pharmacy, Lyon 2010.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, M.D. Implementing pharmacy practice research programs for the management of heart failure. Pharm World Sci 32, 546–548 (2010). https://doi.org/10.1007/s11096-010-9424-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-010-9424-7

Keywords

Search

Navigation